I

Immatics NV
D

IMTX

4.59500
USD
0.00
(0.00%)
مغلق
حجم التداول
29,326
الربح لكل سهم
0
العائد الربحي
-
P/E
-7
حجم السوق
558,522,507
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Immatics NV

القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.